Next Article in Journal
Choice of High-Throughput Proteomics Method Affects Data Integration with Transcriptomics and the Potential Use in Biomarker Discovery
Next Article in Special Issue
Lenalidomide in Multiple Myeloma: Review of Resistance Mechanisms, Current Treatment Strategies and Future Perspectives
Previous Article in Journal
The Dual Blockade of the TIGIT and PD-1/PD-L1 Pathway as a New Hope for Ovarian Cancer Patients
Previous Article in Special Issue
Ixazomib, Lenalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma in Routine Clinical Practice: Extended Follow-Up Analysis and the Results of Subsequent Therapy
 
 
Editorial

Article Versions Notes

Cancers 2022, 14(23), 5759; https://doi.org/10.3390/cancers14235759
Action Date Notes Link
article xml file uploaded 23 November 2022 11:34 CET Original file -
article xml uploaded. 23 November 2022 11:34 CET Update https://www.mdpi.com/2072-6694/14/23/5759/xml
article pdf uploaded. 23 November 2022 11:34 CET Version of Record https://www.mdpi.com/2072-6694/14/23/5759/pdf
article html file updated 23 November 2022 11:35 CET Original file -
article html file updated 1 March 2023 00:28 CET Update -
article html file updated 3 March 2023 22:14 CET Update https://www.mdpi.com/2072-6694/14/23/5759/html
Back to TopTop